BLOOMER HEALTH TECH INC

CAMBRIDGE, MA · Founded 2017 · Medtech · Private

Early intervention therapy coordination and delivery platform for physical, occupational, and speech-language therapists

Claim this profile

Follows are private to you and power your alerts

Updated · bloomerhealth.com

Sector
Medtech
Headquarters
CAMBRIDGE, MA
Founded
2017
Latest Form D
$2.8M, Mar 2020
Total capital
$4.7M
Federal grants
$1.9M
2 awards · 2023–2024
Rank in peer group#77 of 477
Private capital raised
$2.8M
1 Form D · last Mar 2020
80 months since last filing
Federal contracts
None on recordNo federal contract awards found.
Granted patents
5
2 pending · first 2019
Rank in peer group#57 of 477

Capital timeline

20202021202220232024FEDERAL ↑EQUITY ↓Cumulative $4.7M$999K$934K1st Form D$2.8M
20202021202220232024FEDERAL ↑EQUITY ↓Cumulative $4.7M$999K$934K1st Form D$2.8M

Latest events

  • Federal grantHealth and Human S · Phase II · Bloomer Augmented Garment Platform-Barrier Removal for women in cArdiac rehab (BRA)$934K
  • Federal grantHealth and Human S · Phase II · Bloomer Augmented Garment Platform-Barrier Removal for women in cArdiac rehab (BRA)$999K
  • Private capital raisedForm D · SEC · 1st filing$2.8M

Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.

Standing among 477 peers

Line = median

Medtech · Device

  • Federal grants#77 · top 16%
  • Granted patents#57 · top 12%

Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.

Founders and team

Researcher links verified by same-company patents and grants
  • Alicia Chong RodriguezResearcherExecutive Officer, DirectorLinked by 2 patents
  • Aceil HalabyExecutive Officer, DirectorNamed in SEC Form D filings
  • Adam SharkawyDirectorNamed in SEC Form D filings

What it has protected

USPTO · 5 granted of 7
Show all 7 patent records

Regulatory activity · Medtech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.

Sources

Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.

How to read this page

Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.

Data freshness

SEC Form D filings through . SBIR and STTR awards through .